Literature DB >> 33218826

Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies.

Fabio Crocerossa1, Umberto Carbonara2, Francesco Cantiello3, Michele Marchioni4, Pasquale Ditonno5, Maria C Mir6, Francesco Porpiglia7, Ithaar Derweesh8, Lance J Hampton9, Rocco Damiano3, Riccardo Autorino10.   

Abstract

CONTEXT: Radical nephrectomy (RN) is the gold standard treatment for large and locally advanced renal tumors. Although robot-assisted radical nephrectomy (RRN) is being increasingly adopted, it remains unclear whether it offers benefits over standard laparoscopic radical nephrectomy (LRN) or open radical nephrectomy (ORN).
OBJECTIVE: To compare the outcomes of robotic surgery to those of laparoscopic and open surgery in patients undergoing RN for renal cell carcinoma (RCC). EVIDENCE ACQUISITION: A systematic search was performed across MEDLINE, EMBASE, and Web of Science for retrospective and prospective studies comparing RRN to LRN or ORN. A meta-analysis evaluated perioperative safety, effectiveness, survival, and cost-effectiveness outcomes. The weighted mean difference (WMD) and odds ratio (OR) were used to compare continuous and dichotomous variables, respectively. Quality was assessed using the Newcastle-Ottawa scale. Sensitivity analyses were performed to assess the robustness of the estimates. EVIDENCE SYNTHESIS: Twelve studies involving 64 221 patients were identified and included in the analysis. Compared to LRN, RRN was associated with statistically significant longer operative time (WMD 37.44 min; p =  0.03), shorter length of stay (WMD -0.84 days; p =  0.02) and higher total costs (WMD US$4700; p < 0.001). Compared to ORN, RRN was associated with shorter length of stay (WMD -3.06 days; p =  0.002), fewer overall complications (OR 0.56; p <  0.001), lower estimated blood loss (WMD -702 ml; p =  0.01), and higher total hospital costs (WMD US$4520; p =  0.004). There was high heterogeneity across all analyses.
CONCLUSIONS: In patients undergoing RN for RCC, RRN seems to offer some key advantages compared to ORN, including shorter hospitalization and fewer complications. Compared to LRN, RRN provides similar surgical outcomes but at higher total costs. These findings should be interpreted within the limitations of this type of analysis, given high heterogeneity between studies and poor robustness for most outcomes. Randomized clinical studies with long-term follow-up are needed to obtain more definitive results. PATIENT
SUMMARY: In patients with renal cell carcinoma, robot-assisted radical nephrectomy shows perioperative advantages compared to open radical nephrectomy, but not compared to laparoscopic radical nephrectomy.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kidney neoplasms; Laparoscopy; Radical nephrectomy; Robotics; Treatment outcomes

Mesh:

Year:  2020        PMID: 33218826     DOI: 10.1016/j.eururo.2020.10.034

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

Review 1.  Robotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic review.

Authors:  Afra Zahid; Muhammad Ayyan; Minaam Farooq; Huzaifa Ahmad Cheema; Abia Shahid; Faiza Naeem; Muhammad Abdullah Ilyas; Shehreen Sohail
Journal:  J Robot Surg       Date:  2022-05-08

2.  Canadian Urological Association guideline: Management of small renal masses - Full-text.

Authors:  Patrick O Richard; Philippe D Violette; Bimal Bhindi; Rodney H Breau; Wassim Kassouf; Luke T Lavallée; Michael Jewett; John R Kachura; Anil Kapoor; Maxine Noel-Lamy; Michael Ordon; Stephen E Pautler; Frédéric Pouliot; Alan I So; Ricardo A Rendon; Simon Tanguay; Christine Collins; Maryam Kandi; Bobby Shayegan; Andrew Weller; Antonio Finelli; Andrea Kokorovic; Jay Nayak
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 1.862

3.  [Trends in upper urinary tract reconstruction surgery over a decade based on a multi-center database].

Authors:  W Zuo; F Gao; C W Yuan; S W Xiong; Z H Li; L Zhang; K L Yang; X F Li; L Liu; L Wei; P Zhang; B Wang; Y M Gu; H J Zhu; Z Zhao; X S Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

4.  Safety of Prolonged Wait Time for Nephrectomy for Clinically Localized Renal Cell Carcinoma.

Authors:  Nienie Qi; Fangzheng Zhao; Xiaoxiao Liu; Wei Wei; Junqi Wang
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

5.  Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center.

Authors:  Yu Zhang; XiaoJun Tian; Hai Bi; Peng Hong; Zhuo Liu; Ye Yan; Cheng Liu; LuLin Ma
Journal:  J Oncol       Date:  2022-03-17       Impact factor: 4.375

6.  Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery.

Authors:  Rocco Ricciardi; Robert Neil Goldstone; Todd Francone; Matthew Wszolek; Hugh Auchincloss; Alexander de Groot; I-Fan Shih; Yanli Li
Journal:  Surg Endosc       Date:  2022-04-21       Impact factor: 3.453

7.  Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma.

Authors:  Vinson Wai-Shun Chan; Filzah Hanis Osman; Jon Cartledge; Walter Gregory; Michael Kimuli; Naveen S Vasudev; Christy Ralph; Satinder Jagdev; Selina Bhattarai; Jonathan Smith; James Lenton; Tze Min Wah
Journal:  Eur Radiol       Date:  2022-04-06       Impact factor: 7.034

8.  Robot-assisted vs. laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis based on comparative studies.

Authors:  Ruoyu Ji; Zhangyuting He; Shiyuan Fang; Wenjie Yang; Mengchao Wei; Jie Dong; Weifeng Xu; Zhigang Ji
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

Review 9.  Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy.

Authors:  Umberto Carbonara; Daniele Amparore; Cosimo Gentile; Riccardo Bertolo; Selcuk Erdem; Alexandre Ingels; Michele Marchioni; Constantijn H J Muselaers; Onder Kara; Laura Marandino; Nicola Pavan; Eduard Roussel; Angela Pecoraro; Fabio Crocerossa; Giuseppe Torre; Riccardo Campi; Pasquale Ditonno
Journal:  Asian J Urol       Date:  2022-06-14

10.  Impact of COVID-19 on medical education: introducing homo digitalis.

Authors:  Stavros Gravas; Mumtaz Ahmad; Andrés Hernández-Porras; Frederico Furriel; Mario Alvarez-Maestro; Anant Kumar; Kyu-Sung Lee; Evaristus Azodoh; Patrick Mburugu; Rafael Sanchez-Salas; Damien Bolton; Reynaldo Gomez; Laurence Klotz; Sanjay Kulkarni; Simon Tanguay; Sean Elliott; Jean de la Rosette
Journal:  World J Urol       Date:  2020-08-29       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.